Virax Biolabs Group Limited (VRAX:NASDAQ) closed at $1.34 on October 21, 2026, down 2.19% on the day. The stock trades 93.8% below its 52-week high of $21.75 and 1.5% above its 52-week low of $1.32. Virax Biolabs Group Limited is part of the Health Care sector.
In 251 trading sessions since October 20, 2025, VRAX closed higher on 90 days (36%). Its best day was July 9, 2026 (+100.00%) and its worst was July 10, 2026 (-35.85%). The stock moved 10% or more in a single session 36 times. It opened at least 5% above the previous day's high 9 times.
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology.
Find more stocks like VRAX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.